289 related articles for article (PubMed ID: 31689496)
1. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
Seo DH; Lee YH; Park SW; Choi YJ; Huh BW; Lee E; Huh KB; Kim SH; Cha BS
Diabetes Metab; 2020 Oct; 46(5):362-369. PubMed ID: 31689496
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
3. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.
Hashimoto Y; Osaka T; Fukuda T; Tanaka M; Yamazaki M; Fukui M
Endocr J; 2016 Oct; 63(10):877-884. PubMed ID: 27397679
[TBL] [Abstract][Full Text] [Related]
4. Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus.
Cho Y; Park HS; Huh BW; Lee YH; Seo SH; Seo DH; Ahn SH; Hong S; Kim SH
Diabetes Metab J; 2023 Mar; 47(2):232-241. PubMed ID: 36653888
[TBL] [Abstract][Full Text] [Related]
5. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
[TBL] [Abstract][Full Text] [Related]
6. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.
Zhang X; He Z; Si Q; Hu X; Yang L; Gu X; Du L; Wang L; Pan L; Li Y; Li J; Yang B; Gu X
J Diabetes Res; 2022; 2022():2229139. PubMed ID: 36387941
[TBL] [Abstract][Full Text] [Related]
7. [Study on the relationship between non-alcoholic fatty liver disease and sarcopenia in type 2 diabetes mellitus].
Jiang H; Cheng QF; Zhu BZ; Yang Q
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):977-982. PubMed ID: 34814392
[No Abstract] [Full Text] [Related]
8. Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey.
Moon JH; Koo BK; Kim W
J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):964-972. PubMed ID: 34080327
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).
Hong KS; Kim MC; Ahn JH
Int J Chron Obstruct Pulmon Dis; 2020; 15():1005-1014. PubMed ID: 32440112
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): The importance of sarcopenia definition.
Peng TC; Wu LW; Chen WL; Liaw FY; Chang YW; Kao TW
Clin Nutr; 2019 Feb; 38(1):422-428. PubMed ID: 29287676
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
[TBL] [Abstract][Full Text] [Related]
12. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
Su X; Xu J; Zheng C
BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
[TBL] [Abstract][Full Text] [Related]
13. Associations of Serum Vitamin D Level with Sarcopenia, Non-Alcoholic Fatty Liver Disease (NAFLD), and Sarcopenia in NAFLD Among People Aged 50 Years and Older: The Korea National Health and Nutrition Examination Survey IV-V.
Hong J; Shin WK; Lee JW; Lee SY; Kim Y
Metab Syndr Relat Disord; 2022 May; 20(4):210-218. PubMed ID: 35100057
[No Abstract] [Full Text] [Related]
14. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.
Petta S; Ciminnisi S; Di Marco V; Cabibi D; Cammà C; Licata A; Marchesini G; Craxì A
Aliment Pharmacol Ther; 2017 Feb; 45(4):510-518. PubMed ID: 28028821
[TBL] [Abstract][Full Text] [Related]
15. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
[TBL] [Abstract][Full Text] [Related]
17. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort.
Choe HJ; Lee H; Lee D; Kwak SH; Koo BK
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):260-269. PubMed ID: 36403577
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Protein Intake and Sarcopenia in the Elderly with Nonalcoholic Fatty Liver Disease Based on the Fourth and Fifth Korea National Health and Nutrition Examination Survey.
Hong J; Shin WK; Lee JW; Kim Y
Metab Syndr Relat Disord; 2021 Oct; 19(8):452-459. PubMed ID: 34255575
[No Abstract] [Full Text] [Related]
19. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study.
Wang YM; Zhu KF; Zhou WJ; Zhang Q; Deng DF; Yang YC; Lu WW; Xu J; Yang YM
BMC Geriatr; 2021 Jan; 21(1):55. PubMed ID: 33446095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]